Review



antibody against human igf2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems antibody against human igf2
    Antibody Against Human Igf2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 28 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2/pm40679030-279-8-16?v=R%26D+Systems
    Average 93 stars, based on 28 article reviews
    antibody against human igf2 - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    96
    Proteintech anti igf2 bp3 rabbit pab
    Anti Igf2 Bp3 Rabbit Pab, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2/pmc12922985-97-25-31?v=Proteintech
    Average 96 stars, based on 1 article reviews
    anti igf2 bp3 rabbit pab - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    94
    Boster Bio primary antibodies against α sma
    Primary Antibodies Against α Sma, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2/pm41606740-82-1-7?v=Boster+Bio
    Average 94 stars, based on 1 article reviews
    primary antibodies against α sma - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology insulin like growth factor ii igf2
    Characterization of pluripotent stem cell markers in iPSCs. (A) Immunofluorescence staining showing qualitative expression of pluripotency markers SOX2 and TRA-1-60 in iPSC cell lines N7, N9, N11, and N12. Scale bar=200 μm. (B) qRT-PCR analysis of gene expression levels of pluripotency markers NANOG and OCT4 in the iPSC cell lines. Data are presented as mean±SEM from 3 independent experiments (n=3). (C) Immunofluorescence staining showing qualitative expression of the hematopoietic commitment marker <t>IGF2</t> in the iPSC cell lines. Scale bar=200 μm. (D) qRT-PCR analysis of gene expression levels of the hematopoietic commitment marker IGF2 and its receptor IGF1R in the iPSC cell lines. Data are presented as mean±SEM from 3 independent experiments (n=3). iPSCs: induced pluripotent stem cells, IGF2: insulin-like growth factor II.
    Insulin Like Growth Factor Ii Igf2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2/pmc12954770-35-20-25?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    insulin like growth factor ii igf2 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    R&D Systems antibody against human igf2
    Characterization of pluripotent stem cell markers in iPSCs. (A) Immunofluorescence staining showing qualitative expression of pluripotency markers SOX2 and TRA-1-60 in iPSC cell lines N7, N9, N11, and N12. Scale bar=200 μm. (B) qRT-PCR analysis of gene expression levels of pluripotency markers NANOG and OCT4 in the iPSC cell lines. Data are presented as mean±SEM from 3 independent experiments (n=3). (C) Immunofluorescence staining showing qualitative expression of the hematopoietic commitment marker <t>IGF2</t> in the iPSC cell lines. Scale bar=200 μm. (D) qRT-PCR analysis of gene expression levels of the hematopoietic commitment marker IGF2 and its receptor IGF1R in the iPSC cell lines. Data are presented as mean±SEM from 3 independent experiments (n=3). iPSCs: induced pluripotent stem cells, IGF2: insulin-like growth factor II.
    Antibody Against Human Igf2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2/pm40679030-279-8-16?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    antibody against human igf2 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    86
    Signalway Antibody igf2
    <t>IGF2</t> in ApoVs plays a vital role in functional recovery of APOE 4/4-PCs in vitro. a ApoVs derived from APOE 3/3-PCs or HDFs were subjected to transcriptomic analysis and proteomic analysis. b Principal component analysis (PCA) evaluating the similarities of gene expression profiles between ApoVs −HDFs and ApoVs −PCs . c, d Volcano plot and heatmap of differential gene expression analysis between ApoVs −HDFs and ApoVs −PCs . e – h The differentially expressed genes were subjected to GO enrichment analysis. The GO terms related to neuron protection and cognition ( e ), blood–brain barrier maintenance ( f ), DNA replication and transcription ( g ) and cell growth and metabolic ( h ) were significantly enriched in ApoVs −PCs . i, j Volcano plot ( i ) and heatmap ( j ) of protein expression between ApoVs −HDFs and ApoVs −PCs . k, l qPCR and western blot analysis of IGF2 mRNA expression and protein level in ApoVs −HDFs and ApoVs −PCs . m, n IGF2 knockout in APOE 3/3-PCs using the CRISPR-Cas9 system. IGF2 expression was confirmed by western blot analysis. o, p Flow cytometry analysis with annexin V and PI staining revealed cell death rate in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). q Representative dextran leakage in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). r Representative Aβ transcytosis in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). One-way ANOVA with Tukey’s multiple comparison test; ns, non-significant, * P < 0.05; ** P < 0.01; *** P < 0.001
    Igf2, supplied by Signalway Antibody, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2/pmc12613509-168-27-28?v=Signalway+Antibody
    Average 86 stars, based on 1 article reviews
    igf2 - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    93
    R&D Systems anti human igf2
    <t>IGF2</t> in ApoVs plays a vital role in functional recovery of APOE 4/4-PCs in vitro. a ApoVs derived from APOE 3/3-PCs or HDFs were subjected to transcriptomic analysis and proteomic analysis. b Principal component analysis (PCA) evaluating the similarities of gene expression profiles between ApoVs −HDFs and ApoVs −PCs . c, d Volcano plot and heatmap of differential gene expression analysis between ApoVs −HDFs and ApoVs −PCs . e – h The differentially expressed genes were subjected to GO enrichment analysis. The GO terms related to neuron protection and cognition ( e ), blood–brain barrier maintenance ( f ), DNA replication and transcription ( g ) and cell growth and metabolic ( h ) were significantly enriched in ApoVs −PCs . i, j Volcano plot ( i ) and heatmap ( j ) of protein expression between ApoVs −HDFs and ApoVs −PCs . k, l qPCR and western blot analysis of IGF2 mRNA expression and protein level in ApoVs −HDFs and ApoVs −PCs . m, n IGF2 knockout in APOE 3/3-PCs using the CRISPR-Cas9 system. IGF2 expression was confirmed by western blot analysis. o, p Flow cytometry analysis with annexin V and PI staining revealed cell death rate in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). q Representative dextran leakage in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). r Representative Aβ transcytosis in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). One-way ANOVA with Tukey’s multiple comparison test; ns, non-significant, * P < 0.05; ** P < 0.01; *** P < 0.001
    Anti Human Igf2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2/pm41174821-144-9-11?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    anti human igf2 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    96
    Proteintech anti igf2 bp2
    <t>IGF2</t> in ApoVs plays a vital role in functional recovery of APOE 4/4-PCs in vitro. a ApoVs derived from APOE 3/3-PCs or HDFs were subjected to transcriptomic analysis and proteomic analysis. b Principal component analysis (PCA) evaluating the similarities of gene expression profiles between ApoVs −HDFs and ApoVs −PCs . c, d Volcano plot and heatmap of differential gene expression analysis between ApoVs −HDFs and ApoVs −PCs . e – h The differentially expressed genes were subjected to GO enrichment analysis. The GO terms related to neuron protection and cognition ( e ), blood–brain barrier maintenance ( f ), DNA replication and transcription ( g ) and cell growth and metabolic ( h ) were significantly enriched in ApoVs −PCs . i, j Volcano plot ( i ) and heatmap ( j ) of protein expression between ApoVs −HDFs and ApoVs −PCs . k, l qPCR and western blot analysis of IGF2 mRNA expression and protein level in ApoVs −HDFs and ApoVs −PCs . m, n IGF2 knockout in APOE 3/3-PCs using the CRISPR-Cas9 system. IGF2 expression was confirmed by western blot analysis. o, p Flow cytometry analysis with annexin V and PI staining revealed cell death rate in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). q Representative dextran leakage in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). r Representative Aβ transcytosis in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). One-way ANOVA with Tukey’s multiple comparison test; ns, non-significant, * P < 0.05; ** P < 0.01; *** P < 0.001
    Anti Igf2 Bp2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2/pm41100504-227-27-33?v=Proteintech
    Average 96 stars, based on 1 article reviews
    anti igf2 bp2 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    Characterization of pluripotent stem cell markers in iPSCs. (A) Immunofluorescence staining showing qualitative expression of pluripotency markers SOX2 and TRA-1-60 in iPSC cell lines N7, N9, N11, and N12. Scale bar=200 μm. (B) qRT-PCR analysis of gene expression levels of pluripotency markers NANOG and OCT4 in the iPSC cell lines. Data are presented as mean±SEM from 3 independent experiments (n=3). (C) Immunofluorescence staining showing qualitative expression of the hematopoietic commitment marker IGF2 in the iPSC cell lines. Scale bar=200 μm. (D) qRT-PCR analysis of gene expression levels of the hematopoietic commitment marker IGF2 and its receptor IGF1R in the iPSC cell lines. Data are presented as mean±SEM from 3 independent experiments (n=3). iPSCs: induced pluripotent stem cells, IGF2: insulin-like growth factor II.

    Journal: International Journal of Stem Cells

    Article Title: Induced Pluripotent Stem Cells Derived CD71 + CD235a + Erythroblasts Were Increased by Sirtuin 1 Activator

    doi: 10.15283/ijsc25040

    Figure Lengend Snippet: Characterization of pluripotent stem cell markers in iPSCs. (A) Immunofluorescence staining showing qualitative expression of pluripotency markers SOX2 and TRA-1-60 in iPSC cell lines N7, N9, N11, and N12. Scale bar=200 μm. (B) qRT-PCR analysis of gene expression levels of pluripotency markers NANOG and OCT4 in the iPSC cell lines. Data are presented as mean±SEM from 3 independent experiments (n=3). (C) Immunofluorescence staining showing qualitative expression of the hematopoietic commitment marker IGF2 in the iPSC cell lines. Scale bar=200 μm. (D) qRT-PCR analysis of gene expression levels of the hematopoietic commitment marker IGF2 and its receptor IGF1R in the iPSC cell lines. Data are presented as mean±SEM from 3 independent experiments (n=3). iPSCs: induced pluripotent stem cells, IGF2: insulin-like growth factor II.

    Article Snippet: The primary antibodies were rat anti-human SRY-box transcription factor 2 (SOX2) (Invitrogen, A24759), mouse anti-human tumor-related Antigen-1-60 (TRA-1-60) (Invitrogen, A24868), insulin-like growth factor II (IGF2) (Santa Cruz Biotechnology, sc-515805) and rabbit anti-human Runt-related transcription factor 1 (RUNX1) (Abcam, ab35962).

    Techniques: Immunofluorescence, Staining, Expressing, Quantitative RT-PCR, Gene Expression, Marker

    IGF2 in ApoVs plays a vital role in functional recovery of APOE 4/4-PCs in vitro. a ApoVs derived from APOE 3/3-PCs or HDFs were subjected to transcriptomic analysis and proteomic analysis. b Principal component analysis (PCA) evaluating the similarities of gene expression profiles between ApoVs −HDFs and ApoVs −PCs . c, d Volcano plot and heatmap of differential gene expression analysis between ApoVs −HDFs and ApoVs −PCs . e – h The differentially expressed genes were subjected to GO enrichment analysis. The GO terms related to neuron protection and cognition ( e ), blood–brain barrier maintenance ( f ), DNA replication and transcription ( g ) and cell growth and metabolic ( h ) were significantly enriched in ApoVs −PCs . i, j Volcano plot ( i ) and heatmap ( j ) of protein expression between ApoVs −HDFs and ApoVs −PCs . k, l qPCR and western blot analysis of IGF2 mRNA expression and protein level in ApoVs −HDFs and ApoVs −PCs . m, n IGF2 knockout in APOE 3/3-PCs using the CRISPR-Cas9 system. IGF2 expression was confirmed by western blot analysis. o, p Flow cytometry analysis with annexin V and PI staining revealed cell death rate in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). q Representative dextran leakage in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). r Representative Aβ transcytosis in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). One-way ANOVA with Tukey’s multiple comparison test; ns, non-significant, * P < 0.05; ** P < 0.01; *** P < 0.001

    Journal: Translational Neurodegeneration

    Article Title: Transplantation of hiPSC-derived pericytes rescues Alzheimer’s disease phenotypes in APOE 4/4 mice through IGF2-rich apoptotic vesicles

    doi: 10.1186/s40035-025-00512-6

    Figure Lengend Snippet: IGF2 in ApoVs plays a vital role in functional recovery of APOE 4/4-PCs in vitro. a ApoVs derived from APOE 3/3-PCs or HDFs were subjected to transcriptomic analysis and proteomic analysis. b Principal component analysis (PCA) evaluating the similarities of gene expression profiles between ApoVs −HDFs and ApoVs −PCs . c, d Volcano plot and heatmap of differential gene expression analysis between ApoVs −HDFs and ApoVs −PCs . e – h The differentially expressed genes were subjected to GO enrichment analysis. The GO terms related to neuron protection and cognition ( e ), blood–brain barrier maintenance ( f ), DNA replication and transcription ( g ) and cell growth and metabolic ( h ) were significantly enriched in ApoVs −PCs . i, j Volcano plot ( i ) and heatmap ( j ) of protein expression between ApoVs −HDFs and ApoVs −PCs . k, l qPCR and western blot analysis of IGF2 mRNA expression and protein level in ApoVs −HDFs and ApoVs −PCs . m, n IGF2 knockout in APOE 3/3-PCs using the CRISPR-Cas9 system. IGF2 expression was confirmed by western blot analysis. o, p Flow cytometry analysis with annexin V and PI staining revealed cell death rate in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). q Representative dextran leakage in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). r Representative Aβ transcytosis in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). One-way ANOVA with Tukey’s multiple comparison test; ns, non-significant, * P < 0.05; ** P < 0.01; *** P < 0.001

    Article Snippet: The primary antibodies were anti-Aβ 40 (Servicebio, Cat. #GB111197-100, 1:1000), Aβ1-42 Rabbit mAb (ABclonal, Cat. #A24422, 1:1000), phospho-tau-T181 rabbit mAb (ABclonal, Cat. #AP1387, 1:1000, Wuhan, China), and IGF2 (Signalway Antibody, Cat. #32592-2, 1:1000, Frederick, MA).

    Techniques: Functional Assay, In Vitro, Derivative Assay, Gene Expression, Expressing, Western Blot, Knock-Out, CRISPR, Flow Cytometry, Staining, Comparison